Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $89.86 in the prior trading day, Biomarin Pharmaceutical Inc. (NASDAQ: BMRN) closed at $85.12, down -5.27%. In other words, the price has decreased by -$5.27 from its previous closing price. On the day, 2.45 million shares were traded. BMRN stock price reached its highest trading level at $90.01 during the session, while it also had its lowest trading level at $84.89.
Ratios:
Our goal is to gain a better understanding of BMRN by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.24 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 70.22. For the most recent quarter (mrq), Quick Ratio is recorded 1.95 and its Current Ratio is at 3.05. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Bernstein on August 20, 2024, Upgraded its rating to Outperform and sets its target price to $110 from $94 previously.
On May 17, 2024, Robert W. Baird Downgraded its rating to Neutral which previously was Outperform and also lowered its target price recommendation from $104 to $72.
On May 14, 2024, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $113.Evercore ISI initiated its Outperform rating on May 14, 2024, with a $113 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 13 ’24 when Burkhart Erin sold 714 shares for $90.00 per share. The transaction valued at 64,260 led to the insider holds 14,449 shares of the business.
Burkhart Erin bought 714 shares of BMRN for $64,260 on Aug 13 ’24. On May 30 ’24, another insider, Mueller Brian, who serves as the EVP, Chief Financial Officer of the company, sold 5,000 shares for $75.19 each. As a result, the insider received 375,950 and left with 72,159 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BMRN now has a Market Capitalization of 17106821120 and an Enterprise Value of 16080676864. As of this moment, Biomarin’s Price-to-Earnings (P/E) ratio for their current fiscal year is 64.26, and their Forward P/E ratio for the next fiscal year is 27.36. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.49. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.26 while its Price-to-Book (P/B) ratio in mrq is 3.07. Its current Enterprise Value per Revenue stands at 6.213 whereas that against EBITDA is 46.024.
Stock Price History:
Over the past 52 weeks, BMRN has reached a high of $99.56, while it has fallen to a 52-week low of $73.68. The 50-Day Moving Average of the stock is -1.50%, while the 200-Day Moving Average is calculated to be -2.63%.
Shares Statistics:
The stock has traded on average 2.25M shares per day over the past 3-months and 1723280 shares per day over the last 10 days, according to various share statistics. A total of 188.60M shares are outstanding, with a floating share count of 187.98M. Insiders hold about 1.26% of the company’s shares, while institutions hold 98.51% stake in the company. Shares short for BMRN as of 1723680000 were 6648503 with a Short Ratio of 2.96, compared to 1721001600 on 7468190. Therefore, it implies a Short% of Shares Outstanding of 6648503 and a Short% of Float of 3.52.
